MedPath

Evaluation of the effect of adding corticosteroids in the middle ear before Embedding implant in surgery of otosclerosis patients on reducing postoperative vertigo

Phase 3
Recruiting
Conditions
Otosclerosis.
Otosclerosis
Registration Number
IRCT20221114056502N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
35
Inclusion Criteria

Diagnosis of otosclerosis based on audiometry, familial history, air-bone gap more than 20 decibel in 0.5, 1, 2, 3 kilohertz, absens of anomaly and timpano membrane perforation
Age older than 18 y/o
Have surgery indications

Exclusion Criteria

Sensitivity to corticosteroids
Patients with asthma
Patients with hypertension
No referrals patients for primary and secondary evaluations
History of middle ear surgery

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reducing vertigo after surgery. Timepoint: At time of discharge - 4 week after operation. Method of measurement: Vertigo disability questionnaire - Audiometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath